Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 3 , Pages 519-535 , September 2008

Diabetes, Hyperglycemia, and Infections

  • Ashley M. Shilling, MD (Assistant Professor of Anesthesiology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 434 924 2283; Fax: +1 434 982 0019.
  • ,
  • Jacob Raphael, MD (Assistant Professor of Anesthesiology)

References 

  1. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. American Journal of Infection Control. 1996;24:380–388
  2. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infection Control and Hospital Epidemiology. 1999;20:725–730
  3. Gadaleta D, Risucci DA, Nelson RL, et al. Effects of morbid obesity and diabetes mellitus on risk of coronary artery bypass grafting. The American Journal of Cardiology. 1992;70:1613–1614
  4. Lilienfeld DE, Vlahov D, Tenney JH, McLaughlin JS. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. American Journal of Infection Control. 1988;16:3–6
  5. Hoogwerf BJ, Sheeler LR, Licata AA. Endocrine management of the open heart surgical patient. Seminars in Thoracic and Cardiovascular Surgery. 1991;3:75–80
  6. Hruska LA, Smith JM, Hendy MP, et al. Continuous insulin infusion reduces infectious complications in diabetics following coronary surgery. Journal of Cardiac Surgery. 2005;20:403–407
  7. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–513
  8. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical Infectious Diseases. 2005;41:281–288
  9. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  10. Slaughter MS, Olson MM, Lee JT, Ward HB. A fifteen-year wound surveillance study after coronary artery bypass. The Annals of Thoracic Surgery. 1993;56:1063–1068
  11. Edwards FH, Grover FL, Shroyer AL, et al. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. The Annals of Thoracic Surgery. 1997;63:903–908
  12. Ghali WA, Quan H, Brant R. Coronary artery bypass grafting in Canada: national and provincial mortality trends, 1992-1995. CMAJ : Canadian Medical Association journal. 1998;159:25–31
  13. Loop FD, Lytle BW, Cosgrove DM, et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. The Annals of Thoracic Surgery. 1990;49:179–186[discussion: 186–187]
  14. Trick WE, Scheckler WE, Tokars JI, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery. 2000;119:108–114
  15. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine. 2001;345:1359–1367
  16. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. The Annals of Thoracic Surgery. 1997;63:356–361
  17. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. The Annals of Thoracic Surgery. 1999;67:352–360[discussion: 360–362]
  18. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408–1414
  19. McAlister FA, Man J, Bistritz L, et al. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518–1524
  20. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497–1502
  21. Swenne CL, Lindholm C, Borowiec J, et al. Peri-operative glucose control and development of surgical wound infections in patients undergoing coronary artery bypass graft. The Journal of Hospital Infection. 2005;61:201–212
  22. Estrada CA, Young JA, Nifong LW, Chitwood WR. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. The Annals of Thoracic Surgery. 2003;75:1392–1399
  23. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings. 2005;80:862–866
  24. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Annals of Internal Medicine. 2007;146:233–243
  25. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103:687–694
  26. Vriesendorp TM, Morelis QJ, Devries JH, et al. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. European Journal of Vascular and Endovascular Surgery. 2004;28:520–525
  27. Vriesendorp TM, DeVries JH, Hulscher JB, et al. Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial. Critical Care. 2004;8:R437–R442
  28. Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. Journal of Neurosurgical Anesthesiology. 2007;19:156–160
  29. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN. Journal of Parenteral and Enteral Nutrition. 1998;22:77–81
  30. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocrine Practice. 2004;10(Suppl. 2):46–52
  31. Bishop JR, Moul JW, Sihelnik SA, et al. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. The Journal of Urology. 1992;147:386–388
  32. Wilson SK, Carson CC, Cleves MA, Delk JR. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. The Journal of Urology. 1998;159:1537–1539[discussion: 1539-1540]
  33. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infection Control and Hospital Epidemiology. 2001;22:607–612
  34. Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Archives of Surgery. 2006;141:375–380[discussion: 380]
  35. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocrine Journal. 2002;49:531–537
  36. Alberti KG, Thomas DJ. The management of diabetes during surgery. British Journal of Anaesthesia. 1979;51:693–710
  37. Bernard C Leçons sur les phénomènes de la vie communs aux animaux et aux végétaux Paris, France, Bailliere 1878, pp. 564.
  38. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Current Opinion in Clinical Nutrition and Metabolic Care. 1999;2:69–77
  39. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Critical Care Clinics. 2001;17:107–124
  40. Schricker T, Lattermann R, Schreiber M, et al. The hyperglycaemic response to surgery: pathophysiology, clinical implications and modification by the anaesthetic technique. Clinical Intensive Care. 1998;9:118–128
  41. Lattermann R, Carli F, Wykes L, Schricker T. Epidural blockade modifies perioperative glucose production without affecting protein catabolism. Anesthesiology. 2002;97:374–381
  42. Carvalho G, Moore A, Qizilbash B, et al. Maintenance of normoglycemia during cardiac surgery. Anesthesia and Analgesia. 2004;99:319–324
  43. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesthesia and Analgesia. 1999;89:1091–1095
  44. Collier B, Dossett LA, May AK, Diaz JJ. Glucose control and the inflammatory response. Nutrition in Clinical Practice. 2008;23:3–15
  45. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–2072
  46. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA : The Journal of the American Medical Association. 2006;295:1681–1687
  47. McManus LM, Bloodworth RC, Prihoda TJ, et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. Journal of Leukocyte Biology. 2001;70:395–404
  48. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. The New England Journal of Medicine. 1971;284:621–627
  49. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23:9–15
  50. Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabetic Medicine. 1997;14:29–34
  51. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15:256–260
  52. Gin H, Brottier E, Aubertin J. Influence of glycaemic normalization by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients. Journal of Clinical Pathology. 1984;37:1029–1031
  53. Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096–1105
  54. Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144:5329–5338
  55. Rassias AJ, Marrin CA, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia. 1999;88:1011–1016
  56. Bagdade JD, Walters E. Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment. Diabetes. 1980;29:309–311
  57. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes. 1978;27:677–681
  58. Turina M, Miller FN, Tucker C, Polk HC. Effects of hyperglycemia, hyperinsulinemia, and hyperosmolarity on neutrophil apoptosis. Surgical Infections. 2006;7:111–121
  59. Turina M, Miller FN, Tucker CF, Polk HC. Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Annals of Surgery. 2006;243:845–851[discussion: 851–853]
  60. Polk HC, George CD, Wellhausen SR, et al. A systematic study of host defense processes in badly injured patients. Annals of Surgery. 1986;204:282–299
  61. Ditschkowski M, Kreuzfelder E, Rebmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Annals of Surgery. 1999;229:246–254
  62. Balasoiu D, van Kessel KC, van Kats-Renaud HJ, et al. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care. 1997;20:392–395
  63. Tan JS, Anderson JL, Watanakunakorn C, Phair JP. Neutrophil dysfunction in diabetes mellitus. The Journal of Laboratory and Clinical Medicine. 1975;85:26–33
  64. von Kanel R, Mills PJ, Dimsdale JE. Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sciences. 2001;69:255–262
  65. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. The Journal of Clinical Investigation. 1998;101:1905–1915
  66. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes. 1989;38:1031–1035
  67. Zozulinska D, Majchrzak A, Sobieska M, et al. Serum interleukin-8 level is increased in diabetic patients. Diabetologia. 1999;42:117–118
  68. Mooradian AD, Reed RL, Meredith KE, Scuderi P. Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients. Diabetes Care. 1991;14:63–65
  69. Mohanty P, Hamouda W, Garg R, et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. The Journal of Clinical Endocrinology and Metabolism. 2000;85:2970–2973
  70. Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990;39:271–275
  71. Verhofstad MH, Hendriks T. Complete prevention of impaired anastomotic healing in diabetic rats requires preoperative blood glucose control. The British Journal of Surgery. 1996;83:1717–1721
  72. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. The Journal of Clinical Investigation. 1990;85:929–932
  73. Bohlen HG, Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. The American Journal of Physiology. 1993;265:H219–H225
  74. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;97:1695–1701
  75. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radical Biology & Medicine. 1994;16:383–391
  76. Richardson RM, Ptasienski J, Hosey MM. Functional effects of protein kinase C-mediated phosphorylation of chick heart muscarinic cholinergic receptors. The Journal of Biological Chemistry. 1992;267:10127–10132
  77. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings. 2003;78:1471–1478
  78. Talbot TR. Diabetes mellitus and cardiothoracic surgical site infections. American Journal of Infection Control. 2005;33:353–359
  79. Geerlings SE, Brouwer EC, Gaastra W, et al. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. Journal of Medical Microbiology. 1999;48:535–539
  80. Blondet JJ, Beilman GJ. Glycemic control and prevention of perioperative infection. Current Opinion in Critical Care. 2007;13:421–427
  81. Dandona P, Thusu K, Hafeez R, et al. Effect of hydrocortisone on oxygen free radical generation by mononuclear cells. Metabolism. 1998;47:788–791
  82. Krinsley J. Perioperative glucose control. Current Opinion in Anaesthesiology. 2006;19:111–116
  83. Svedjeholm R, Svensson S, Ekroth R, et al. Trauma metabolism and the heart: studies of heart and leg amino acid flux after cardiac surgery. The Thoracic and Cardiovascular Surgeon. 1990;38:1–5

 Disclosures: This review was funded with departmental and institutional support.

PII: S1521-6896(08)00056-6

doi: 10.1016/j.bpa.2008.06.005

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 3 , Pages 519-535 , September 2008